International Data Protection Authorities Joint Statement on AI Imagery Risks

Sixty-one international data protection authorities have issued a joint statement outlining privacy risks associated with AI-generated imagery. The statement addresses concerns about the creation of realistic images and videos of individuals without consent, particularly highlighting potential harms to children. It urges responsible AI development and deployment.

Paxton Secures Injunction Against Xcel Energy for Wildfire Risk

Texas Attorney General Ken Paxton has secured a temporary injunction against Xcel Energy, requiring immediate action to replace damaged utility poles and conduct rigorous inspections to mitigate wildfire risks. This action follows the devastating Smokehouse Creek Fire, which Xcel Energy admitted was caused by a broken utility pole.

Supreme Court Denies Huntington Beach Housing Law Challenge

California Attorney General Rob Bonta announced the U.S. Supreme Court denied Huntington Beach's challenge to state housing laws. This decision upholds a Ninth Circuit ruling and requires Huntington Beach to comply with state housing mandates, with ongoing litigation in state court to ensure compliance.

OSFI Superintendent Discusses Mortgage Regulation and Financial System Resilience

OSFI Superintendent Peter Routledge discussed the future of mortgage regulation, including the retention of stress tests and LTI limits, and OSFI's ongoing regulatory modernization efforts. The speech highlighted OSFI's commitment to adapting its framework based on feedback from regulated institutions.

EU Legislation and Notices - February 23, 2026

The EU published several legislative acts and decisions on February 23, 2026. These include implementing regulations concerning restrictive measures in Russia, amendments to active substance approvals for biocidal products, and a decision on Iceland's participation in the Union Space Programme.

MHRA Licenses Brensocatib for Non-Cystic Fibrosis Bronchiectasis

The MHRA has granted a marketing authorisation for brensocatib (Brinsupri), the first medicine specifically designed to treat non-cystic fibrosis bronchiectasis (NCFB) in patients aged 12 years and older. This marks a significant advancement in treatment options for NCFB patients in the UK.

MHRA Class 2 Medicines Recall: KidNaps Melatonin Oral Solution

The MHRA has issued a Class 2 medicines recall for all batches of KidNaps Melatonin 1mg in 1ml Oral Solution due to out-of-specification stability results. Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are conducting the recall at the wholesaler and pharmacy level.

NY Attorney General Warns of Price Gouging Ahead of Winter Storm

New York Attorney General Letitia James has issued a consumer alert warning New Yorkers about potential price gouging of essential goods and services ahead of a winter storm. Violations can result in penalties of up to $25,000 per violation.

European AI Innovation Month Announced

The European Commission and the Irish Presidency of the Council have announced the European AI Innovation Month, a series of events scheduled from mid-October to mid-November 2026. The initiative aims to discuss and showcase AI development and deployment in Europe, culminating in the European Apply AI Summit.

R.R. v. LYFT, Inc. - Personal Injury Product Liability

A new civil case, R.R. v. LYFT, Inc., was filed on February 21, 2026, in the U.S. District Court for the Northern District of California. The case involves personal injury and product liability under diversity jurisdiction. A recent filing indicates a transfer for consolidated pretrial proceedings.